Cited by 1,397Immune cells in cancerCancer, Hypoxia, and MetabolismImmune Response and Inflammation

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.

Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages

Open access
Palsson-McDermott, Eva M., Curtis, Anne M., Goel, Gautam, Lauterbach, Mario A.R., Sheedy, Frederick J., Gleeson, Laura E., van den Bosch, Mirjam W.M., Quinn, Susan R., Domingo-Fernandez, Raquel, Johnston, Daniel G.W., Jiang, Jian-kang, Israelsen, William J., Keane, Joseph, Thomas, Craig, Clish, Clary, Vander Heiden, Matthew, Xavier, Ramnik J., O’Neill, Luke A.J.·2015·Cell Metabolism

Abstract

Macrophages activated by the TLR4 agonist LPS undergo dramatic changes in their metabolic activity. We here show that LPS induces expression of the key metabolic regulator Pyruvate Kinase M2 (PKM2). Activation of PKM2 using two well-characterized small molecules, DASA-58 and TEPP-46, inhibited LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes. Activation of PKM2 attenuated an LPS-induced proinflammatory M1 macrophage phenotype while promoting traits typical of an M2 macrophage. We show that LPS-induced PKM2 enters into a complex with Hif-1α, which can directly bind to the IL-1β promoter, an event that is inhibited by activation of PKM2. Both compounds inhibited LPS-induced glycolytic reprogramming and succinate production. Finally, activation of PKM2 by TEPP-46 in vivo inhibited LPS and Salmonella typhimurium-induced IL-1β production, while boosting production of IL-10. PKM2 is therefore a critical determinant of macrophage activation by LPS, promoting the inflammatory response.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

LPS induces PKM2 in macrophages, where dimeric/monomeric PKM2 complexes with Hif-1α and binds the IL-1β promoter to promote Warburg-like glycolysis and pro-inflammatory activation. Forcing PKM2 into tetramers with DASA-58 or TEPP-46 inhibits Hif-1α activity, IL-1β induction, glycolytic reprogramming, and succinate accumulation, while shifting macrophages toward an M2-like/IL-10-high phenotype and impairing bacterial killing in vivo.

Key findings

  • LPS induced PKM2 expression and tyrosine 105 phosphorylation in BMDMs; Pkm2 mRNA increased approximately 2.8-fold after 24 hours, and phospho-PKM2 showed a 10.3-fold increase in relative band intensity, consistent with inactive monomer/dimer formation.
  • PKM2 activators DASA-58 and TEPP-46 promoted tetramerization, inhibited LPS-induced nuclear translocation of PKM2, and blocked LPS-induced Hif-1α protein, pro-IL-1β, Il1b mRNA, and the Hif-1α target Ldha, without affecting IL-6 or TNF.
  • LPS increased PKM2–Hif-1α association and binding of both to the IL-1β promoter; TEPP-46/DASA-58 inhibited this binding. PKM2 deletion reduced LPS-induced Hif-1α, Il1β, and Ldha, and reduced glycolysis, while increasing oxidative phosphorylation.
  • DASA-58 blocked LPS-induced succinate and glycolytic intermediates; LPS caused up to a ten-fold increase in glycolysis that was markedly inhibited by TEPP-46 and DASA-58. In vivo, TEPP-46 reduced LPS- and Salmonella typhimurium-induced IL-1β, boosted IL-10, and increased bacterial dissemination.

Methods

  • Primary BMDMs and peritoneal cells from C57BL/6 mice, RAW 264.7 macrophages, and conditional PKM2fl/fl BMDMs were treated with LPS, TEPP-46, DASA-58, tamoxifen, Mtb, or S. typhimurium.
  • Main assays included Western blotting, DSS crosslinking, size-exclusion chromatography, nuclear/cytosolic fractionation, ELISA, qPCR, co-immunoprecipitation, oligonucleotide pulldown, sequential ChIP, Seahorse extracellular flux analysis, microarray profiling, and LC-MS metabolomics.
  • In vivo models used LPS-induced sepsis and S. typhimurium infection in mice treated with TEPP-46 or vehicle, measuring serum cytokines, peritoneal cell IL-1β, and bacterial CFU in liver/spleen.

Limitations

  • The paper does not include a dedicated limitations section.
  • Limitations evident from the text: most mechanistic work uses mouse BMDMs/PECs and RAW cells; in vivo infection experiments use TEPP-46 only because DASA-58 is not pharmacokinetically validated in vivo; some data are not shown; and the mechanism by which PKM2 promotes IL-10 production is stated to require further analysis.
  • The Mtb ELISA results are described as means ± SEMs for one representative experiment with n=2, limiting statistical robustness.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2014.12.005

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 26 cited sources checked · 0 supported · 0 flagged

Show all 74 claims

  • It may state two separate claims as one. 51
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1
57 of 57
  • The paper relies on this without support.

    There is only limited information on the precise molecular determinants of the profound metabolic change in LPS-activated macrophages.

    “There is only limited information on the precise molecular determinants of this profound change in metabolism.”
  • The paper relies on this without support.

    LPS-activated macrophages have a high demand for biosynthetic precursors and increased energy demand, and these events are required for the cells to respond to infection or tissue injury during inflammation.

    “In macrophages activated with the TLR4 agonist LPS there is a high demand for biosynthetic precursors including proteins, lipids, and nucleic acids as well as increased energy demand. These events are required for the cells to respond to infection or tissue injury during inflammation.”
  • The paper relies on this without support.

    PKM2 enters the nucleus as a dimer.

    “Since previous reports have established that PKM2 enters the nucleus as a dimer, we then carried out further DSS cross-linking studies in order to support a model for nuclear exclusion of PKM2 following treatment with our small molecule activators.”
  • The paper relies on this without support.

    Hif-1α is stabilized by succinate inhibiting PHDs.

    “Hif-1α will also be stabilized by succinate inhibiting PHDs, providing further regulation of Hif-1α.”
  • The paper relies on this without support.

    Mycobacterium tuberculosis utilizes TLR2, TLR6 and TLR9.

    “This extended our observation beyond TLR4 and LPS to a bacterial pathogen that utilizes TLR2, TLR6 and TLR9.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Chromatography treatment is named TEPP-58 instead of TEPP-46

    Minor

    The methods name TEPP-58 for the size-exclusion experiment, while the results identify TEPP-46 as the treatment in that experiment.

1 of 1

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

See all 1,397

Metadata

Authors
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., Jiang, J.-K., Israelsen, W. J., Keane, J., Thomas, C., Clish, C., Vander Heiden, M., Xavier, R. J., & O’Neill, L. A. J.
Affiliations
  • Broad Institute (US)
  • Trinity College Dublin (IE)
  • National Institutes of Health (US)
  • Koch Institute for Integrative Cancer Research At MIT (US)
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2015-01
Volume
21
Issue
1
Pages
65-80
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2153586956
Cited by
1,397
References
38
Citations by year
2026: 154 · 2025: 177 · 2024: 186 · 2023: 133 · 2022: 132 · 2021: 161 · 2020: 140 · 2019: 81 · 2018: 85 · 2017: 77 · 2016: 51 · 2015: 19
FWCI
38.04
Type
journal article
Language
en
Update notices
erratum (2015-02-03)
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
  • Health Research Board
  • Seventh Framework Programme (FP7-2007-2013, HEALTH-14-2011-281608)
  • National Institutes of Health
  • European Research Council
  • Science Foundation Ireland
  • Wellcome Trust
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
PKM2, HIF-1α, IL-1β, Warburg effect, macrophage polarization, M1/M2 macrophages, lipopolysaccharide stimulation, TLR4, glycolytic reprogramming, succinic acid, TEPP-46, IL-10, Salmonella typhimurium, inflammation, macrophage metabolism
MeSH terms
Animals, Bone Marrow Cells, Cells, Cultured, Glycolysis, Lipopolysaccharides, Macrophage Activation, Macrophages, Mice, Inbred C57BL, Promoter Regions, Genetic, Protein Binding, Pyruvate Kinase, RNA, Messenger, Salmonella typhimurium, Gene Expression, Enzyme Activators, Toll-Like Receptor 4, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review